LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.17 Million USD | -103.86% |
| 2022 | -2.53 Million USD | -221.9% |
| 2021 | 2.08 Million USD | -92.57% |
| 2020 | 28.01 Million USD | 613.53% |
| 2019 | 3.92 Million USD | 114.92% |
| 2018 | -26.31 Million USD | -37.82% |
| 2017 | -19.09 Million USD | 21.38% |
| 2016 | -24.28 Million USD | 11.52% |
| 2015 | -27.45 Million USD | -46.86% |
| 2014 | -18.69 Million USD | -27.06% |
| 2013 | -14.71 Million USD | 10.56% |
| 2012 | -16.44 Million USD | 18.3% |
| 2011 | -20.13 Million USD | 10.98% |
| 2010 | -22.61 Million USD | 1.7% |
| 2009 | -23 Million USD | -45.44% |
| 2008 | -15.81 Million USD | -147.64% |
| 2007 | -6.38 Million USD | 58.42% |
| 2006 | -15.35 Million USD | -1506.5% |
| 2005 | 1.09 Million USD | 22.97% |
| 2004 | 888 Thousand USD | 0.0% |
| 2002 | 595 Thousand USD | -11.19% |
| 2001 | 670 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -7.71 Million USD | -49.07% |
| 2024 Q2 | -3.85 Million USD | 49.97% |
| 2024 Q3 | -18.27 Million USD | 30.68% |
| 2023 Q4 | -5.17 Million USD | -342.22% |
| 2023 FY | -5.17 Million USD | -103.86% |
| 2023 Q1 | -172 Thousand USD | 93.22% |
| 2023 Q2 | -2.68 Million USD | -1458.72% |
| 2023 Q3 | -1.17 Million USD | 56.36% |
| 2022 Q2 | -3.57 Million USD | -21123.53% |
| 2022 Q3 | -188 Thousand USD | 94.74% |
| 2022 Q4 | -2.53 Million USD | -1250.0% |
| 2022 Q1 | 17 Thousand USD | -99.18% |
| 2022 FY | -2.53 Million USD | -221.9% |
| 2021 Q4 | 2.08 Million USD | 336.86% |
| 2021 FY | 2.08 Million USD | -92.57% |
| 2021 Q1 | 23.91 Million USD | -14.62% |
| 2021 Q2 | 17.93 Million USD | -25.04% |
| 2021 Q3 | -879 Thousand USD | -104.9% |
| 2020 Q3 | 47.19 Million USD | -23.04% |
| 2020 Q4 | 28.01 Million USD | -40.65% |
| 2020 Q2 | 61.32 Million USD | 1270.76% |
| 2020 Q1 | 4.47 Million USD | 13.96% |
| 2020 FY | 28.01 Million USD | 613.53% |
| 2019 FY | 3.92 Million USD | 114.92% |
| 2019 Q3 | -5.29 Million USD | 17.4% |
| 2019 Q4 | 3.92 Million USD | 174.1% |
| 2019 Q1 | -8.06 Million USD | 69.36% |
| 2019 Q2 | -6.41 Million USD | 20.47% |
| 2018 Q1 | -22.78 Million USD | -19.3% |
| 2018 Q3 | -20.1 Million USD | -2.37% |
| 2018 Q4 | -26.31 Million USD | -30.91% |
| 2018 FY | -26.31 Million USD | -37.82% |
| 2018 Q2 | -19.63 Million USD | 13.8% |
| 2017 Q3 | -37.51 Million USD | -24.55% |
| 2017 Q1 | -25.81 Million USD | -6.27% |
| 2017 FY | -19.09 Million USD | 21.38% |
| 2017 Q4 | -19.09 Million USD | 49.1% |
| 2017 Q2 | -30.12 Million USD | -16.7% |
| 2016 Q4 | -24.28 Million USD | 29.9% |
| 2016 FY | -24.28 Million USD | 11.52% |
| 2016 Q3 | -34.65 Million USD | -18.2% |
| 2016 Q2 | -29.31 Million USD | -13.01% |
| 2016 Q1 | -25.94 Million USD | 5.5% |
| 2015 Q2 | -19.43 Million USD | -14.13% |
| 2015 Q1 | -17.02 Million USD | 8.92% |
| 2015 Q4 | -27.45 Million USD | -16.18% |
| 2015 FY | -27.45 Million USD | -46.86% |
| 2015 Q3 | -23.62 Million USD | -21.61% |
| 2014 Q1 | -12.5 Million USD | 15.0% |
| 2014 FY | -18.69 Million USD | -27.06% |
| 2014 Q2 | -23.51 Million USD | -88.04% |
| 2014 Q3 | -18.35 Million USD | 21.94% |
| 2014 Q4 | -18.69 Million USD | -1.84% |
| 2013 Q4 | -14.71 Million USD | -7.96% |
| 2013 Q1 | -15.3 Million USD | 6.97% |
| 2013 Q2 | -14.91 Million USD | 2.56% |
| 2013 Q3 | -13.62 Million USD | 8.61% |
| 2013 FY | -14.71 Million USD | 10.56% |
| 2012 FY | -16.44 Million USD | 18.3% |
| 2012 Q4 | -16.44 Million USD | 20.31% |
| 2012 Q2 | -20.16 Million USD | -2.75% |
| 2012 Q3 | -20.63 Million USD | -2.37% |
| 2012 Q1 | -19.62 Million USD | 2.53% |
| 2011 Q4 | -20.13 Million USD | 12.8% |
| 2011 Q1 | -19.1 Million USD | 15.53% |
| 2011 Q2 | -21.4 Million USD | -12.05% |
| 2011 Q3 | -23.08 Million USD | -7.86% |
| 2011 FY | -20.13 Million USD | 10.98% |
| 2010 FY | -22.61 Million USD | 1.7% |
| 2010 Q3 | -27.29 Million USD | -7.17% |
| 2010 Q2 | -25.47 Million USD | -8.33% |
| 2010 Q1 | -23.51 Million USD | -2.21% |
| 2010 Q4 | -22.61 Million USD | 17.16% |
| 2009 Q4 | -23 Million USD | -17.24% |
| 2009 FY | -23 Million USD | -45.44% |
| 2009 Q2 | -16.67 Million USD | -18.97% |
| 2009 Q1 | -14.01 Million USD | 11.4% |
| 2009 Q3 | -19.62 Million USD | -17.69% |
| 2008 Q1 | -5.39 Million USD | 15.47% |
| 2008 FY | -15.81 Million USD | -147.64% |
| 2008 Q4 | -15.81 Million USD | -20.53% |
| 2008 Q3 | -13.12 Million USD | -23.77% |
| 2008 Q2 | -10.6 Million USD | -96.39% |
| 2007 FY | -6.38 Million USD | 58.42% |
| 2007 Q1 | -13.23 Million USD | 13.83% |
| 2007 Q2 | -12.47 Million USD | 5.75% |
| 2007 Q3 | -7.75 Million USD | 37.85% |
| 2007 Q4 | -6.38 Million USD | 17.61% |
| 2006 FY | -15.35 Million USD | -1506.5% |
| 2006 Q4 | -15.35 Million USD | -490.91% |
| 2006 Q3 | 3.92 Million USD | 33.37% |
| 2006 Q1 | 1.68 Million USD | 54.21% |
| 2006 Q2 | 2.94 Million USD | 74.94% |
| 2005 FY | 1.09 Million USD | 22.97% |
| 2005 Q4 | 1.09 Million USD | 0.0% |
| 2004 Q4 | 888 Thousand USD | 0.0% |
| 2004 FY | 888 Thousand USD | 0.0% |
| 2002 FY | 595 Thousand USD | -11.19% |
| 2001 FY | 670 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 300.465% |
| AngioDynamics, Inc. | -70.14 Million USD | 92.624% |
| AtriCure, Inc. | -9.81 Million USD | 47.29% |
| Avinger, Inc. | 10.12 Million USD | 151.126% |
| Azenta, Inc. | -618.47 Million USD | 99.163% |
| BioLife Solutions, Inc. | 7.25 Million USD | 171.336% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.211% |
| Daxor Corporation | 755.65 Thousand USD | 784.7% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -251.973% |
| Femasys Inc. | -15.01 Million USD | 65.542% |
| GlucoTrack, Inc. | -4.29 Million USD | -20.438% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 113.442% |
| Hologic, Inc. | 374.4 Million USD | 101.382% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.357% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.806% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 26.476% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -20.678% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -20.678% |
| Masimo Corporation | 804 Million USD | 100.644% |
| Microbot Medical Inc. | -2.28 Million USD | -126.334% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 46.08% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 101.712% |
| Nephros, Inc. | -2.47 Million USD | -109.389% |
| NovoCure Limited | 355.42 Million USD | 101.456% |
| NEXGEL, Inc. | 98 Thousand USD | 5379.592% |
| NEXGEL, Inc. | 98 Thousand USD | 5379.592% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 108.761% |
| OraSure Technologies, Inc. | -276.9 Million USD | 98.131% |
| Pro-Dex, Inc. | 10.91 Million USD | 147.398% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 85.31% |
| Predictive Oncology Inc. | -5.87 Million USD | 11.885% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 270.805% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.207% |
| Repligen Corporation | -39.51 Million USD | 86.908% |
| Sanara MedTech Inc. | 6.64 Million USD | 177.864% |
| STAAR Surgical Company | -147.2 Million USD | 96.485% |
| Sharps Technology, Inc. | -3.01 Million USD | -71.728% |
| Utah Medical Products, Inc. | -92.52 Million USD | 94.408% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.263% |
| Jin Medical International Ltd. | -2.81 Million USD | -83.703% |